Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging technology company developing healthcare solutions, and its Joint Venture partner, Ainnova Tech, Inc. (Ainnova), a leading ...

Investing.com -- PTC (NASDAQ: PTC) Therapeutics (NASDAQ: PTCT) stock rose 9% after the company announced that the U.S. Food and Drug Administration (FDA) has approved its drug SEPHIENCE (sepiapterin) ...

Investing.com -- Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) stock surged 12% after the U.S. Food and Drug Administration (FDA) approved EMPAVELI® (pegcetacoplan) as the first treatment for C3 ...

Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging technology company developing healthcare ...

Investing.com -- Atossa Therapeutics Inc (NASDAQ: ATOS) stock surged 11.4% premarket following positive feedback from the U.S. Food and Drug Administration (FDA) regarding the company’s proposed dose ...

Nations that lead in clinical trials get earlier access to breakthrough therapies, shape global regulatory norms, and ...

We recently compiled a list of 10 Best Mid Cap Stocks to Buy According to Billionaires. Mesoblast Limited stands tenth on our ...

We recently compiled a list of 10 Best Mid Cap Stocks to Buy According to Billionaires. Disc Medicine, Inc. stands sixth on ...

Investing.com -- Dyne Therapeutics, Inc. (NASDAQ: DYN) reported a second quarter loss that slightly missed analyst expectations as the clinical-stage biotech company continues to advance its ...

"This was primarily driven by 18% growth seen from the oncology portfolio, which has done well as a result of key drugs such ...

In April, 2025, Demis Hassabis, the Nobel Prize-winning CEO of Google DeepMind, appeared on the US television show 60 Minutes and suggested that all diseases could be curable with the help of ...